For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the emergence of this treatment and the formulated version represents a true breakthrough . These groundbreaking therapies preserve the transthyretin protein, halting its damaging build-up and reducing the impact of the illness. People are now exper